Recombinant RSV virus expression systems and vaccines

Details for Australian Patent Application No. 2006200619 (hide)

Owner MedImmune Vaccines, Inc.

Inventors Li, Shengqiang; Bryant, Marty; Jin, Hong; Tang, Roderick

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006200619

Parent 2003200297

Filing date 13 February 2006

Wipo publication date 9 March 2006

Acceptance publication date 13 December 2007

International Classifications

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

Event Publications

2 March 2006 Complete Application Filed

9 March 2006 Application Open to Public Inspection

  Published as AU-B-2006200619

25 May 2006 Change of Name(s) of Applicant(s), Section 104

  Aviron, Inc. The name of the applicant has been changed to MedImmune Vaccines, Inc.

13 December 2007 Application Accepted

  Published as AU-B-2006200619

10 April 2008 Standard Patent Sealed

9 October 2008 Alteration of Name

  The name of the patentee has been altered to MedImmune, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006200620-Start-up method for draft tube mixing

2006200618-Enzymatic resolution of aryl and thiosubstituted acids